Remove Genetics Remove Genomics Remove Life Science Remove Reagent
article thumbnail

Up to 8 recipients to be awarded grants for genomic research

Drug Discovery World

Beckman Coulter Life Sciences has released a call for registrations for its SPRI Grants for Genomic Research, which the company describes as part of its commitment to the next generation of researchers and scientists. . Applications will be accepted until 15 December 2022. .

Genome 52
article thumbnail

Illumina Partners with Sequoia Capital for its 3rd Life Science Incubator, This One in China

The Pharma Data

Illumina , the world’s leading DNA sequencing and array-based technologies company, is partnering with Sequoia Capital China, an investment firm, to launch a life sciences incubator in China. It is dubbed the Sequoia Capital China Intelligent Healthcare Genomics Incubator, Powered by Illumina.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Modernizing cell culture processes for the next wave of genomic medicine

Pharmaceutical Technology

The field of genomic medicine has reached a true turning point. With scientists fervently developing mRNA vaccines, nucleic acid therapeutics, and viral vector-based gene therapies, clinicians are set to have a growing number of tools available to treat a wide range of conditions, from infectious diseases to genetic disorders and more.

Genome 244
article thumbnail

Assay Development Scientist Jobs: What to Know About the Field

XTalks

This could involve tweaking experimental conditions, changing reagents or redesigning the assay. Additionally, advances in technologies in fields like genomics, proteomics and cell biology necessitate specialized assays.

article thumbnail

CRISPR breakthroughs: New solutions for common diseases

Drug Discovery World

Rolf Turk , Senior Manager, Genomics Medicine at Integrated DNA Technologies, examines how CRISPR is being used to enhance cancer therapies. Nucleic acid-based diagnostics, which typically require PCR reagents and laboratory equipment, are crucial for identifying, treating, and preventing common infectious diseases.

DNA 98